APLS Amends Exec Separation Plan, Accelerates Equity Upon Change Control, Expands Good Reason Exclusion for C-Level Officers
Apellis Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $41.03
+0.1% in 7d after detection
Post-detection moves
1h
—
1d
0.0%
3d
+0.1%
7d
+0.1%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS